PI3K/Akt/mTOR inhibitors (Endo/Jubilant Biosys)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePI3K/Akt/mTOR inhibitors (Endo/Jubilant Biosys)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitorsProto-oncogene proteins c-akt inhibitorsPI3-kinase class I inhibitors
TargetsPI3-kinase class IProto-oncogene proteins c-aktSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJubilant Pharmova Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndo Health Solutions IncJubilant Pharmova LtdEndo International Plc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A